Quarterly report pursuant to Section 13 or 15(d)

Debt - Mortgage Notes And Other Debt (Details)

v3.3.0.814
Debt - Mortgage Notes And Other Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2015
Dec. 31, 2014
Mortgage notes and other debt payables    
Current portion of notes payable $ 78,508 $ 13,455 [1]
Other long-term liabilities 4,735 2,434
EirGen Pharma Limited, OPKO Europe and Bio Reference    
Mortgage notes and other debt payables    
Current portion of notes payable 1,029 608
Other long-term liabilities 2,347 2,435
Total mortgage notes and other debt $ 3,376 $ 3,043
[1] As of December 31, 2014, total assets include $7.6 million and total liabilities include $12.1 million related to SciVac Ltd (“SciVac”). SciVac was a consolidated variable interest entity which we deconsolidated in July 2015. Refer to Note 5. SciVac’s consolidated assets were owned by SciVac and SciVac’s consolidated liabilities had no recourse against us.